Search results for "Llar"

showing 10 items of 3592 documents

Fully Percutaneous Transaxillary Aortic Valve Replacement With Effective Bailout Plan for Vascular Complications.

2020

medicine.medical_specialtyPercutaneousbusiness.industryAortic Valve StenosisTAVRsubclavian approachtransaxillary TAVRmedicine.diseaseSurgeryTAVITranscatheter Aortic Valve ReplacementPostoperative ComplicationsTreatment Outcometransaxillary TAVIAortic valve replacementRisk FactorsAortic ValveHeart Valve ProsthesismedicineHumansCardiology and Cardiovascular MedicinebusinessBailoutJACC. Cardiovascular interventions
researchProduct

Upper-Extremity Blocks

1988

Brachial plexus block was first performed in 1885 by William Steward Halsted, who used cocaine and direct exposure of the roots in the neck to accomplish the block. In 1911, Hirschel and Kulenkampff described the first percutaneous brachial plexus block by the axillary and supraclavicular routes respectively. Since these historic reports, the efficacy of brachial plexus block has been confirmed, and the block is now commonly used to provide upperextremity anesthesia.

medicine.medical_specialtyPercutaneousbusiness.industryMedian nerveSurgerybody regionsAxillary arterymedicine.arteryBlock (telecommunications)medicineUlnar nervebusinessBrachial plexusRadial nerveBrachial plexus block
researchProduct

Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs.

1993

Abstract Rolipram (0·1–1000 μg kg−1, i.v.) reduced the increase in microvascular permeability induced by platelet-activating factor (PAF; 50 ng kg−1, i.v.) at different sites of the guinea-pig airways. Rolipram (1–100μg kg−1, i.v.) inhibited histamine (30μg kg−1, i.v.)-and bradykinin (0·3 μg kg, i.v.)-induced airway microvascular leakage. These effects of rolipram were obtained at doses which inhibit histamine (7–20 μg kg−1 min−1)-induced bronchoconstriction (IC50 = 3 ± 1 μg kg, i.v.) without depressing arterial blood pressure in the guinea-pig. Aminophylline (50 mg kg−1) did not change the effect of PAF. The anti-exudative effect of rolipram is of potential therapeutic value in asthma.

medicine.medical_specialtyPhosphodiesterase InhibitorsGuinea PigsPharmaceutical ScienceBradykininVascular permeabilityBlood PressureBronchiBradykininCapillary Permeabilitychemistry.chemical_compoundInternal medicinemedicineAnimalsDrug InteractionsPlatelet Activating FactorRolipramPharmacologyPlatelet-activating factorMicrocirculationAminophyllinePyrrolidinonesTracheaEndocrinologymedicine.anatomical_structurechemistryBronchoconstrictionAminophyllinemedicine.symptomRolipramHistaminemedicine.drugBlood vesselEvans BlueHistamineThe Journal of pharmacy and pharmacology
researchProduct

ROLIPRAM INHIBITS PAF-INDUCED AIRWAY MICROVASCULAR LEAKAGE IN GUINEA-PIG - A COMPARISON WITH MILRINONE AND THEOPHYLLINE

1992

The effects of 3 phosphodiesterase (PDE) inhibitors, rolipram (PDE IV), milrinone (PDE III) and theophylline (non-selective) on PAF (50 ng kg-1; iv)-induced airway vascular leakage have been evaluated in guinea-pigs. Rolipram (3-300 micrograms kg-1; iv) reduced the increase in permeability induced by PAF at all airway levels whereas milrinone (10-1000 micrograms kg-1; iv) and theophylline (30 mg kg-1; iv) were without effects. The anti-leakage activity of rolipram may be of therapeutic value in asthma.

medicine.medical_specialtyPhosphodiesterase InhibitorsPyridonesGuinea PigsRespiratory SystemVascular permeabilityCapillary Permeabilitychemistry.chemical_compoundTheophyllineInternal medicinemedicineAnimalsPharmacology (medical)TheophyllinePlatelet Activating FactorRolipramPharmacologybiologyCyclic nucleotide phosphodiesterasePlatelet-activating factorbusiness.industryPhosphodiesterasePyrrolidinonesEndocrinologychemistryEnzyme inhibitorbiology.proteinMilrinonebusinessRolipramEvans BlueMilrinonemedicine.drug
researchProduct

Giant enchondroma recurrence of the proximal phalanx of the fifth finger: A case report

2020

Enchondroma (EC) is a benign and cartilage-forming tumor that causes intramedullary lesions. Moreover, EC is the most common bone tumor in the phalanges and metacarpal bones of the hand, deforming the structure and causing pain and functional limitation. The management of this neoplasia is the surgical treatment and the approach that is well-accepted consists in the curettage followed by the void augmentation with biological or synthetic fillers. The results from surgery are usually good and the recurrence rate is low (2-15%). In this article we report a case of EC recurrence of the proximal phalanx of the fifth finger of the hand after curettage and grafting. The patient was treated with t…

medicine.medical_specialtyProximal phalanxmedicine.medical_treatment030231 tropical medicineEnchondromaCase ReportMetacarpal boneslaw.inventionIntramedullary rod03 medical and health sciences0302 clinical medicinelawmedicineEnchondroma030212 general & internal medicineSurgical treatmentbusiness.industryGeneral MedicinePhalanxmedicine.diseaseCurettageSurgeryAmputationTsuge techniqueEnchondroma hand Tsuge techniqueEnchondroma; hand; Tsuge techniquehandbusiness
researchProduct

"Doctor, tengo un bulto en la axila". Adenomegalia siliconomatosa postmamoplastia de aumento: a propósito de ocho casos

2010

La aparición de adenopatías axilares asociadas a mamoplastia de aumento mediante prótesis de silicona es un hecho infrecuente, no excepcional, y muy preocupante para paciente y cirujano. Hemos hecho una revisión de 1697 historias clínicas de pacientes sometidas a mamoplastia de aumento mediante prótesis de silicona al objeto de estudiar la relación entre roturas protésicas y adenopatías axilares Las 1697 pacientes se dividieron en grupos que cumplían 1, 2, 3, 5 y 7 años de haber sido intervenidas. Revisamos sus historias clínicas y estudiamos las que con posterioridad a la cirugía habían consultado por sospecha de rotura protésica y adenopatías axilares. No encontramos roturas protésicas an…

medicine.medical_specialtyPrótesis de mamabusiness.industryAugmentation MammoplastyMamoplastiaAdenopatías axilares siliconomatosastechnology industry and agricultureAxillary LymphadenopathyMedicineSurgerybusinessSurgery
researchProduct

Onkoplastische Sofortrekonstruktions-Technik unter Erhalt des Mamillen-Areola-Komplexes nach radikaler Resektion eines Mammakarzinoms mit zentralem S…

2001

There are few breast-conserving therapies (BCT) for centrally located breast cancer. The present paper describes a BCT for breast cancers in such a location, which permits conservation of the nipple-areola complex (NAC), provided this has not been infiltrated. After histological detection of the breast cancer by punch biopsy, a central segmental mastectomy and an axillary dissection are performed. An immediate reconstruction of the subareolar defect is carried out by means of a local flap technique, thus conserving the NAC.

medicine.medical_specialtyPunch Biopsymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentObstetrics and GynecologySegmental Mastectomymedicine.diseaseSurgeryBreast cancerBiopsymedicineAxillary DissectionSurgical Flapsskin and connective tissue diseasesRadical resectionbusinessMastectomyZentralblatt für Gynäkologie
researchProduct

Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer.

2021

Abstract Background Sentinel lymph node biopsy is the gold standard surgical technique for axillary staging in patients with clinically node-negative. However, it is still uncertain what is the optimal number of sentinel lymph nodes (SLNs) to be removed to reduce the false-negative rate. The aim of this study was to investigate whether patients with a single negative SLN have a worse prognosis than those with two or more negative SLNs. Methods A retrospective review was conducted on a large series of SLN-negative breast cancer patients. Survival outcomes and regional recurrence rate were evaluated according to the number of removed SLNs. Secondly, the contribution of different adjuvant ther…

medicine.medical_specialtyRD1-811SurvivalSentinel lymph nodeUrologyBreast NeoplasmsBreast cancerBreast cancerBiopsyMedicineHumansSurvival analysisRC254-282Retrospective Studiesmedicine.diagnostic_testbusiness.industrySentinel Lymph Node BiopsyOptimal numberResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensRetrospective cohort studySentinel nodemedicine.diseasePrognosisAxillamedicine.anatomical_structureOncologyAxillary stagingAxillaLymph Node ExcisionSurgeryFemaleLymphLymph NodesNeoplasm Recurrence LocalSentinel Lymph NodebusinessFalse-negative rateWorld journal of surgical oncology
researchProduct

OC2.01: Examination of the fetal brain by three-dimensional ultrasound: potential for routine neurosonographic studies

2005

Objective: To evaluate the role of three-dimensional (3D) ultrasound in the assessment of the fetal brain and its potential for routine neurosonographic studies. Methods: We studied prospectively 202 consecutive brain fetuses between 16 and 24 weeks’ gestation. A 3D-ultrasound volume of the fetal head was acquired transabdominally. The entire brain anatomy was later analyzed by a sonologist expert in neonatal cranial sonography using the multiplanar images. The quality of the conventional planes obtained (coronal, sagittal and axial, at different levels) and the ability to visualize properly the major brain anatomic structures were evaluated. Results: Acceptable rendered cerebral volumes we…

medicine.medical_specialtyRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryObstetrics and GynecologyGeneral MedicineAnatomyCorpus callosumFourth ventricleCisterna magnamedicine.anatomical_structureReproductive MedicinemedicineCerebellar vermisRadiology Nuclear Medicine and imagingCingulate sulcusFetal head3D ultrasoundRadiologybusinessCavum vergaeUltrasound in Obstetrics and Gynecology
researchProduct

Kinin receptors in human vascular tissue: their role in atheromatous disease

1997

Using samples of many human blood vessels, obtained at autopsy and specific antibodies directed to peptide sequences of the kinin B1 and B2 receptors, we demonstrate the localisation of these receptors within the human vascular system using standard immunolabelling techniques. In large elastic arteries and veins, kinin receptors are present only in the endothelial cells whereas in all muscular arteries and arterioles, these receptors are present in both the endothelial and smooth muscle cells. The identification of kinin receptors in human blood vessels confirms that kinins may modulate both vascular permeability and contractility. The incidental finding at histology, of patchy atheromatous…

medicine.medical_specialtyReceptor Bradykinin B2EndotheliumArteriosclerosisMolecular Sequence DataImmunocytochemistryEnzyme-Linked Immunosorbent AssayVascular permeabilityBiologyReceptor Bradykinin B1Muscle Smooth VascularVeinsCapillary PermeabilityContractilityAntibody SpecificityInternal medicinemedicineHumansVasoconstrictor AgentsAmino Acid SequenceReceptorVascular tissuePharmacologyStaining and LabelingReceptors BradykininArteriesKininImmunohistochemistryMolecular WeightArteriolesmedicine.anatomical_structureEndocrinologycardiovascular systemImmunohistochemistryKallikreinsAutopsyEndothelium VascularTissue KallikreinsMuscle ContractionImmunopharmacology
researchProduct